John R. Ieni

2.8k total citations
35 papers, 2.3k citations indexed

About

John R. Ieni is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, John R. Ieni has authored 35 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 12 papers in Pharmacology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in John R. Ieni's work include Dementia and Cognitive Impairment Research (11 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). John R. Ieni is often cited by papers focused on Dementia and Cognitive Impairment Research (11 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). John R. Ieni collaborates with scholars based in United States, France and Japan. John R. Ieni's co-authors include Raymond Pratt, Rachelle S. Doody, Johann Meunier, Tangui Maurice, Samantha Rogers, Carlos Perdomo, Laurence R. Meyerson, Richard C. Mohs, John C. Morris and George Provenzano and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

John R. Ieni

34 papers receiving 2.1k citations

Peers

John R. Ieni

PMH

PHARM

PHYSI

CMN

Hans Jörg Möbius Germany

John J. Sramek United States

Elias Schwam United States

Ravi Anand United States

Albrecht Stöffler Germany

Carlos Perdomo United States

Douglas Galasko United States

I. Gergel United States

Sean Lilienfeld United States

Richard D. Hartman United States

Hans Jörg Möbius Germany

John R. Ieni

911 ×1.0

PMH

863 ×1.0

PHARM

934 ×1.6

PHYSI

452 ×0.9

618 ×1.4

CMN

Citations per year, relative to John R. Ieni John R. Ieni (= 1×) peers Hans Jörg Möbius

Countries citing papers authored by John R. Ieni

Since Specialization

Citations

This map shows the geographic impact of John R. Ieni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Ieni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Ieni more than expected).

Fields of papers citing papers by John R. Ieni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Ieni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Ieni. The network helps show where John R. Ieni may publish in the future.

Co-authorship network of co-authors of John R. Ieni

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Ieni. A scholar is included among the top collaborators of John R. Ieni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Ieni. John R. Ieni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miner, Philip B., et al.. (2010). Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24‐h intragastric acidity and oesophageal acid exposure: a randomized study in gastro‐oesophageal reflux disease patients with a history of nocturnal heartburn. Alimentary Pharmacology & Therapeutics. 31(9). 991–1000. 9 indexed citations

Doody, Rachelle S., Jody Corey‐Bloom, Richard Zhang, et al.. (2008). Safety and Tolerability of Donepezil at Doses up to 20 mg/day. Drugs & Aging. 25(2). 163–174. 36 indexed citations

Meunier, Johann, John R. Ieni, & Tangui Maurice. (2006). The anti‐amnesic and neuroprotective effects of donepezil against amyloid β_25‐35peptide‐induced toxicity in mice involve an interaction with theσ₁receptor. British Journal of Pharmacology. 149(8). 998–1012. 253 indexed citations

Maurice, Tangui, Johann Meunier, Bihua Feng, John R. Ieni, & Daniel T. Monaghan. (2006). Interaction with σ1 Protein, but Not N-Methyl-d-aspartate Receptor, Is Involved in the Pharmacological Activity of Donepezil. Journal of Pharmacology and Experimental Therapeutics. 317(2). 606–614. 69 indexed citations

Meunier, Johann, John R. Ieni, & Tangui Maurice. (2006). Antiamnesic and Neuroprotective Effects of Donepezil against Learning Impairments Induced in Mice by Exposure to Carbon Monoxide Gas. Journal of Pharmacology and Experimental Therapeutics. 317(3). 1307–1319. 29 indexed citations

Feldman, Howard, Serge Gauthier, Jane Hecker, et al.. (2005). Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo‐controlled trial. International Journal of Geriatric Psychiatry. 20(6). 559–569. 92 indexed citations

Schindler, Rachel, et al.. (2004). P1-344 Donepezil is safe and well tolerated in Alzheimer's disease patients, at doses of up to 20 mg/day. Neurobiology of Aging. 25. S195–S196. 2 indexed citations

Geldmacher, David, George Provenzano, Thomas McRae, Vera Mastey, & John R. Ieni. (2003). Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease. Journal of the American Geriatrics Society. 51(7). 937–944. 216 indexed citations

Krishnan, Kousik, H. Cecil Charles, P. Murali Doraiswamy, et al.. (2003). Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease. American Journal of Psychiatry. 160(11). 2003–2011. 212 indexed citations

10.

Tune, Larry E., Paul J. Tiseo, John R. Ieni, et al.. (2003). Donepezil HCl (E2020) Maintains Functional Brain Activity in Patients With Alzheimer Disease: Results of a 24-Week, Double-Blind, Placebo-Controlled Study. American Journal of Geriatric Psychiatry. 11(2). 169–177. 112 indexed citations

11.

Ferguson, James M., Ram Shrivastava, Stephen M. Stahl, et al.. (2001). Reemergence of Sexual Dysfunction in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 62(1). 24–29. 83 indexed citations

12.

Provenzano, George, S Duttagupta, Tom McRae, et al.. (2001). PPN13: DELAYS IN NURSING HOME PLACEMENT FOR PATIENTS WITH ALZHEIMER'S DISEASE ASSOCIATED WITH TREATMENT WITH DONEPEZIL MAY HAVE HEALTH CARE COST-SAVING IMPLICATIONS. Value in Health. 4(2). 158–158. 3 indexed citations

13.

Rogers, Samantha, Rachelle S. Doody, Raymond Pratt, & John R. Ieni. (2000). Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study. European Neuropsychopharmacology. 10(3). 195–203. 216 indexed citations

14.

Mohs, Richard C., Rachelle S. Doody, Jonathan Morris, et al.. (1999). Donepezil preserves functional status in Alzheimer's disease patients: Results from a 1-year prospective placebo-controlled attrition study. European Neuropsychopharmacology. 9. 328–328. 17 indexed citations

15.

Beer, Bernard, John R. Ieni, Wenhui Wu, et al.. (1994). A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine Hypnotic. The Journal of Clinical Pharmacology. 34(4). 335–344. 70 indexed citations

16.

Stoff, David M., et al.. (1991). Platelet 3H-imipramine binding, serotonin uptake, and plasma α1 acid glycoprotein in disruptive behavior disorders. Biological Psychiatry. 29(5). 494–498. 17 indexed citations

17.

Thurmond, John B., Gary B. Freeman, Joseph S. Soblosky, John R. Ieni, & John W. Brown. (1990). Effects of dietary tyrosine on L-dopa- and amphetamine-induced changes in locomotor activity and neurochemistry in mice. Pharmacology Biochemistry and Behavior. 37(2). 259–266. 4 indexed citations

18.

Ieni, John R. & Laurence R. Meyerson. (1988). The 5-HT1A receptor probe [3H]8-OH-DPAT labels the 5-HT transporter in human platelets. Life Sciences. 42(3). 311–320. 23 indexed citations

19.

Ieni, John R., Ethel Tobach, Stephen R. Zukin, Gordon A. Barr, & H. M. van Praag. (1985). Multiple [3H]imipramine binding sites in brains of male and female Fawn-Hooded and Long-Evans rats. European Journal of Pharmacology. 112(2). 261–264. 26 indexed citations

20.

Gold, Richard M., et al.. (1977). Delayed or precocious hyperphagia after symmetrical or asymmetrical hypothalamic knife cuts in male and female weanling rats. Physiology & Behavior. 18(2). 275–281. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact